- Home
- RCKT vs MYN Comparison
RCKT vs MYN Comparison
Compare RCKT & MYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RCKT | MYN |
|---|---|---|
| Founded | 1999 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 340.9M | 390.0M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | RCKT | MYN |
|---|---|---|
| Price | $3.51 | $9.91 |
| Analyst Decision | Buy | |
| Analyst Count | 14 | 0 |
| Target Price | ★ $29.12 | N/A |
| AVG Volume (30 Days) | ★ 1.9M | 86.0K |
| Earning Date | 11-06-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 4.12% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.19 | $8.47 |
| 52 Week High | $13.35 | $10.62 |
Technical Indicators
Market Signals| Indicator | RCKT | MYN |
|---|---|---|
| Relative Strength Index (RSI) | 55.01 | 38.26 |
| Support Level | $3.19 | $9.89 |
| Resistance Level | $3.60 | $9.98 |
| Average True Range (ATR) | 0.19 | 0.07 |
| MACD | 0.02 | -0.02 |
| Stochastic Oscillator | 70.65 | 6.90 |
Price Performance
Historical ComparisonAbout RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.
About MYN Blackrock MuniYield New York Quality Fund Inc.
Blackrock Muniyield NY Quality FD, Inc is a closed-end management investment company. Its objective is to provide shareholders with a high level of current income exempt from federal income taxes. The Fund invests in long-term municipal obligations that are investment grade quality or are considered by the Fund's investment adviser to be of comparable quality, at the time of investment.